Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients who have had a first episode of unprovoked venous thromboembolism have a high risk of recurrence after anticoagulants are discontinued. Aspirin may be effective in preventing a recurrence of venous thromboembolism. METHODS: We randomly assigned 822 patients who had completed initial anticoagulant therapy after a first episode of unprovoked venous thromboembolism to receive aspirin, at a dose of 100 mg daily, or placebo for up to 4 years. The primary outcome was a recurrence of venous thromboembolism. RESULTS: During a median follow-up period of 37.2 months, venous thromboembolism recurred in 73 of 411 patients assigned to placebo and in 57 of 411 assigned to aspirin (a rate of 6.5% per year vs. 4.8% per year; hazard ratio with aspirin, 0.74; 95% confidence interval [CI], 0.52 to 1.05; P=0.09). Aspirin reduced the rate of the two prespecified secondary composite outcomes: the rate of venous thromboembolism, myocardial infarction, stroke, or cardiovascular death was reduced by 34% (a rate of 8.0% per year with placebo vs. 5.2% per year with aspirin; hazard ratio with aspirin, 0.66; 95% CI, 0.48 to 0.92; P=0.01), and the rate of venous thromboembolism, myocardial infarction, stroke, major bleeding, or death from any cause was reduced by 33% (hazard ratio, 0.67; 95% CI, 0.49 to 0.91; P=0.01). There was no significant between-group difference in the rates of major or clinically relevant nonmajor bleeding episodes (rate of 0.6% per year with placebo vs. 1.1% per year with aspirin, P=0.22) or serious adverse events. CONCLUSIONS: In this study, aspirin, as compared with placebo, did not significantly reduce the rate of recurrence of venous thromboembolism but resulted in a significant reduction in the rate of major vascular events, with improved net clinical benefit. These results substantiate earlier evidence of a therapeutic benefit of aspirin when it is given to patients after initial anticoagulant therapy for a first episode of unprovoked venous thromboembolism. (Funded by National Health and Medical Research Council [Australia] and others; Australian New Zealand Clinical Trials Registry number, ACTRN12605000004662.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis
Kahn, S. R., Shrier, I., Julian, J. A., Ducruet, T., Arsenault, L., Miron, M.-J., Roussin, A., Desmarais, S., Joyal, F., Kassis, J., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00004 · Cited by 854
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Cited by
Items 301–400 of 600
Wojtukiewicz, M. Z., Sierko, E., Tomkowski, W. Z., Zawilska, K., Undas, A., Podolak‐Dawidziak, M., Wysocki, P. J., Krzakowski, M. J., Warzocha, K., & Windyga, J. (2016) · Nowotwory Journal of Oncology · doi:10.5603/njo.2016.0062 · Cited by 8
Folkerts, K., Broughton, J., Sheikh, U., & Mckaig, S. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1658589 · Cited by 8
Thromboembolic characteristics and role of anticoagulation in long-standing Fontan circulation
Westhoff‐Bleck, M., Klages, C. S., Zwadlo, C., Sonnenschein, K., Sieweke, J., Bauersachs, J. K., Bertram, H., & Grosser, U. (2022) · International Journal of Cardiology Congenital Heart Disease · doi:10.1016/j.ijcchd.2022.100328 · Cited by 8
The place of new oral anticoagulants in travel medicine
Ringwald, J., Grauer, M., Eckstein, R., & Jelínek, T. (2013) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2013.11.005 · Cited by 8
Medical Management of Pulmonary Embolism: Beyond Anticoagulation
Hsu, N. Y.-H., Wang, T. S., Friedman, O., & Barjaktarević, I. (2017) · Techniques in vascular and interventional radiology · doi:10.1053/j.tvir.2017.07.004 · Cited by 8
Incidental Pulmonary Embolism After Coronary Artery Bypass Surgery: Long-Term Clinical Follow-Up
Beck, K. S., Cho, E. K., Moon, M. H., Kim, D., Song, H., & Jung, J. I. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.17.18186 · Cited by 8
Aspirin in the secondary prevention of unprovoked thromboembolism: the WARFASA and ASPIRE studies
(GrAM), G. D. A. M., Birocchi, S., Scannella, E., Ferrari, L., & Podda, G. M. (2013) · Internal and Emergency Medicine · doi:10.1007/s11739-013-0961-7 · Cited by 8
Covariance-Based Space Regularization for Few-Shot Class Incremental Learning
Hu, Y., Yang, G., Tan, Z., Huang, X., Huang, K., & Wang, Q. (2025) · IEEE Winter Conference on Applications of Computer Vision · doi:10.1109/wacv61041.2025.00926 · Cited by 7
Bejjani, A., Khairani, C. D., Krishnathasan, D., Rizzo, S. M., Sato, A., Bacare, B., Scimeca, G., Tristani, A., Armero, A., Porio, N. D., et al. (2025) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuaf109 · Cited by 7
Venous thromboembolism management: where do novel anticoagulants fit?
Spyropoulos, A. C., & Turpie, A. G. G. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.803462 · Cited by 7
Subtype-Specific Plasma Signatures of Platelet-Related Protein Releasate in Acute Pulmonary Embolism
Baidildinova, G., ten Cate, V., Nagler, M., Panova‐Noeva, M., Rapp, S., Köck, T., Prochaska, J. H., Heitmeier, S., Gerdes, C., Schwers, S., et al. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.10.005 · Cited by 7
Liu, Z., Tan, J., Deng, Y.-R., Hua, L., & Guo, T. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9120414 · Cited by 7
SEQUEL: Semi-Supervised Preference-based RL with Query Synthesis via Latent Interpolation
Marta, D., Holk, S., Pek, C., & Leite, I. (2024) · Proceedings - IEEE International Conference on Robotics and Automation/Proceedings · doi:10.1109/icra57147.2024.10610534 · Cited by 7
King, M. A., & Pryce, R. (2013) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9893-6 · Cited by 7
The Current and Future Landscape of Urinary Thromboxane Testing to Evaluate Atherothrombotic Risk
Neath, S., Jefferies, J. L., Berger, J. S., Wu, A. H. B., McConnell, J. P., Boone, J. L., McCullough, P. A., Jesse, R. L., & Maisel, A. S. (2014) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0739 · Cited by 7
Patel, R. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s100299 · Cited by 7
Non-vitamin K antagonist oral anticoagulants for the prevention of recurrent venous thromboembolism
Bauersachs, R. M. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.05.022 · Cited by 7
Duke, A. J., Bowen, S., Baig, S., Cohen, D., Komatsu, D. E., & Nicholson, J. (2023) · Journal of orthopaedic surgery · doi:10.1177/10225536231173329 · Cited by 7
Silent pulmonary thromboembolism in neurosurgery patients: Report of 2 cases and literature review
Tian, R., Gao, J., Chen, A., Bao, X., Guan, J., Feng, M., Li, Y., Ma, W., Ren, Z., Wang, R., et al. (2016) · Medicine · doi:10.1097/md.0000000000004589 · Cited by 7
Orale Antikoagulation mit Vitamin K-Antagonisten – ein Update
Sucker, C., & Litmathe, J. (2017) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-017-0577-z · Cited by 7
Extended anticoagulation for unprovoked venous thromboembolism
Castellucci, L. A., de Wit, K., Garcia, D. A., Ortel, T. L., & Gal, G. L. (2018) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12121 · Cited by 7
Variational Autoencoder-Based Framework for Retail Sales Prediction
Li, F., Wang, L., & Jin, B. (2024) · IEEE Access · doi:10.1109/access.2024.3502657 · Cited by 6
Deep Generative Replay-based Class-incremental Continual Learning in sEMG-based Pattern Recognition
Kanoga, S., Karakida, R., Hoshino, T., Okawa, Y., & Tada, M. (2024) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc53108.2024.10781686 · Cited by 6
Bozkurt, A. K., Akay, H. T., Çalkavur, T., Şırlak, M., Balkanay, O. O., Uğuz, E., Doğancı, S., Polat, A., Bayrak, S., Bozok, Ş., et al. (2021) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2021.22121 · Cited by 6
Analysis of Prior Aspirin Treatment on in-Hospital Outcome of Geriatric COVID-19 Infected Patients
Zekri-Nechar, K., Barberán, J., Zamorano‐León, J. J., Durbán, M., Andrés-Castillo, A., Cuéllar, C. N., López-Farré, A. J., López‐de‐Andrés, A., Jiménez‐García, R., & Martínez-Martínez, C. H. (2022) · Medicina · doi:10.3390/medicina58111649 · Cited by 6
Pain Management - From Acute to Chronic and Beyond
Aslanidis, T., & Nouris, C. (2023) · Pharmaceutical science. · doi:10.5772/intechopen.107760 · Cited by 6
Pulmonary embolism hotline 2012: Recent and expected trials
Lankeit, M., & Konstantinides, S. (2013) · Hämostaseologie · doi:10.5482/hamo-12-12-0024 · Cited by 6
Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism
Imberti, D., Pomero, F., Benedetti, R., & Fenoglio, L. M. (2016) · Internal and Emergency Medicine · doi:10.1007/s11739-016-1521-8 · Cited by 6
Freed, J. A., & Bauer, K. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00014-5 · Cited by 6
Bingzheng, X., Jingnan, R., Bao, L., & Jianping, C. (2021) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13442 · Cited by 6
Aspirin in secondary prevention of recurrent venous thromboembolism
Boonyawat, K., & Crowther, M. A. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1196-4 · Cited by 6
Duration of Anticoagulation for Venous Thromboembolic Events
Smilowitz, N. R., Mega, J. L., & Berger, J. S. (2014) · Circulation · doi:10.1161/circulationaha.114.010456 · Cited by 6
Gómez, J. R. M., Duque, L. N. H., & Palacio, J. J. C. (2015) · Revista Med · doi:10.18359/rmed.1744 · Cited by 6
Thrombophilia diagnosis: a retrospective analysis of a single-center experience
Spychalska-Zwolińska, M., Zwoliński, T., Mieczkowski, A., & Budzyński, J. (2015) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000332 · Cited by 6
Lin, Y., Lin, M., Wu, V. C., Chen, Y., Chang, J.-J., Chu, P., Lip, G. Y. H., & Chen, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.775564 · Cited by 6
Lenchus, J. D., Biehl, M., Cabrera, J. L., de Moraes, A. G., & Dezfulian, C. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616648265 · Cited by 6
Unconventional approaches to the prevention of cancer associated thrombosis
Zwicker, J. I. (2014) · Thrombosis Research · doi:10.1016/s0049-3848(14)50008-4 · Cited by 6
Modeling Venous Thrombosis In Vitro: More Than Just (Valve) Pocket Change
Wolberg, A. S. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310919 · Cited by 6
CaliMatch: Adaptive Calibration for Improving Safe Semi-Supervised Learning
Bae, J., Kim, S. B., & Do, H. (2025) · IEEE/CVF International Conference on Computer Vision (ICCV) · doi:10.1109/iccv51701.2025.00275 · Cited by 5
CI-VAE: a Generative Deep Learning Model for Class-Specific Data Interpolation
Nabian, M., Eftekhari, Z., & Wong, C. W. (2024) · IEEE Conference on Artificial Intelligence (CAI) · doi:10.1109/cai59869.2024.00067 · Cited by 5
Aprile, G., Fontanella, C., Lutrino, E. S., Ferrari, L., Casagrande, M., Cardellino, G. G., Rosati, G., & Fasola, G. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i14.2131 · Cited by 5
The Role of Platelet and its Interaction with Aspirin
Zúñiga-Cerón, L. F., Saavedra-Torres, J. S., & Amézquita, C. A. N. (2016) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v64n2.53789 · Cited by 5
Quelle est la durée du traitement anticoagulant pour une EP/TVP proximale ?
Couturaud, F., Girard, P., Laporte, S., & Sanchez, O. (2019) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2019.05.022 · Cited by 5
Thachil, J. V. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1735453 · Cited by 5
Li, D., Liu, Y., Song, Y. H., & Wen, A. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2026002 · Cited by 5
Lammers, D. T., Scerbo, M. H., Davidson, A., Pommerening, M. J., Tomasek, J. S., Wade, C. E., Cardenas, J. C., Jansen, J. O., Miller, C. C., & Holcomb, J. B. (2023) · Trauma Surgery & Acute Care Open · doi:10.1136/tsaco-2023-001140 · Cited by 5
Semi-Supervised Learning Under General Causal Models
Moore, A., Shim, H., Zhu, J., & Gong, M. (2024) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2024.3392750 · Cited by 5
Schatoff, D., Jung, I. Y., & Goldberg, I. J. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.05.009 · Cited by 5
The history and historical treatments of deep vein thrombosis: toward the era of new anticoagulants
Galanaud, J. ‐., Laroche, J.-P., & Righini, M. (2025) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.07.019 · Cited by 5
Aspirin Increases the Risk of Venous Thromboembolism in Surgical Patients
Barmparas, G., Jain, M., Mehrzadi, D., Melo, N., Chung, R., Bloom, M. B., Ley, E. J., & Margulies, D. R. (2014) · The American Surgeon · doi:10.1177/000313481408001002 · Cited by 5
Treatment of deep vein thrombosis
Lauw, M. N., & Buller, H. R. (2014) · doi:10.2217/fmeb2013.13.98 · Cited by 5
El‐Ashmawy, I. M., Ebeid, M. A., Aljohani, M., Alhumaydhi, F. A., & Aljohani, A. S. M. (2022) · Journal of Taibah University for Science · doi:10.1080/16583655.2021.2021054 · Cited by 5
Unveiling Latent Spaces with Variational Autoencoders
Shanckin, S., Mayank, Singh, A., & Patwadi, R. (2023) · IEEE International Conference on Service Operations and Logistics, and Informatics (SOLI) · doi:10.1109/soli60636.2023.10425383 · Cited by 5
Seoane, L., Cortes, M. M., Cancela, M. E. A., Furmento, J., Baranchuk, A. M., & Conde, D. G. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1484281 · Cited by 5
Barry, A. R., Semchuk, W., Thompson, A., LeBras, M. H., & Koshman, S. L. (2020) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163520909137 · Cited by 5
Sapai, S., Loo, J. Y., Ding, Z. Y., Tan, C. P., Phan, R. C. ‐., Baskaran, V. M., & Nurzaman, S. G. (2023) · Proceedings - IEEE International Conference on Robotics and Automation/Proceedings · doi:10.1109/icra48891.2023.10160662 · Cited by 5
Success Probabilities of L 2 -norm Regularized Babai Detectors and Maximization
Chang, X.-W., Lu, Q., & Xu, Y. (2023) · IEEE International Symposium on Information Theory (ISIT) · doi:10.1109/isit54713.2023.10206541 · Cited by 4
Sound Source Separation Using Latent Variational Block-Wise Disentanglement
Helwani, K., Togami, M., Smaragdis, P., & Goodwin, M. M. (2024) · IEEE International Conference on Acoustics, Speech, and Signal Processing Workshops (ICASSPW) · doi:10.1109/icasspw62465.2024.10626303 · Cited by 4
Schrör, K., & Rauch, B. H. (2013) · HAL · Cited by 4
Perspective Chapter: Aspirin – The Wonder Drug
Ishola, A. A. (2024) · Pharmaceutical science. · doi:10.5772/intechopen.111571 · Cited by 4
del Pozo, M. M., Asenjo, M. M., Franco‐Moreno, A., de Antonio, E. U., & Valle, F. G. (2024) · Revista Clínica Española · doi:10.1016/j.rce.2024.07.007 · Cited by 4
Cai, Y., Li, D., Wu, S., Shao, M., Hong, S., Qi, J., & Sun, H. (2025) · IEEE Sensors Journal · doi:10.1109/jsen.2024.3521502 · Cited by 4
Azam, F., Awaida, C. J., Dogaroiu, A., & Odobescu, A. (2025) · Microsurgery · doi:10.1002/micr.70029 · Cited by 4
Cardi, S., Barco, S., Wolf, S., Rodríguez, P. D., Pérez‐Pinar, M., Skride, A., Tazi, Z. M., López‐Sáez, J. B., Marchena, P. J., Monréal, M., et al. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02706-4 · Cited by 4
Investigación de la trombofilia venosa. Presente y futuro
Vilalta, N., & Souto, J. C. (2014) · Angiología · doi:10.1016/j.angio.2014.03.001 · Cited by 4
Nouveaux anticoagulants oraux dans le traitement curatif de la maladie thromboembolique veineuse
Bertoletti, L., Lega, J., Moulin, N., Buchmuller, A., Mismetti, P., & Decousus, H. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.06.001 · Cited by 4
Postintervention duration of anticoagulation in venous surgery
ten Cate‐Hoek, A. J., Prins, M. H., Wittens, C. H. A., & Cate, H. T. (2013) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355513476415 · Cited by 4
Use of aspirin for the prevention of lower extremity deep venous thrombosis
Sadaghianloo, N., Jean‐Baptiste, E., Declémy, S., Hassen‐Khodja, R., & Dardik, A. (2014) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2013.10.051 · Cited by 4
Initial and Long-Term Treatment of Pulmonary Embolism: Current Approach and Future Perspectives
Ageno, W., & Donadini, M. P. (2018) · Hämostaseologie · doi:10.1055/s-0038-1641605 · Cited by 4
Dalbeni, A., Susca, N., Daidone, M. G., Rossi, I., Giontella, A., Cimellaro, A., Talerico, G., Pietrangelo, A., Sesti, G., Zaccone, V., et al. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03432-3 · Cited by 4
An Algorithmic Approach to Management of Venous Thromboembolism
Dhakal, P., Gundabolu, K., & Bhatt, V. R. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616652727 · Cited by 4
Platelet–vessel wall interactions and drug effects
Twarock, S., Bagheri, S., Bagheri, S., & Hohlfeld, T. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.008 · Cited by 4
Place actuelle des anticoagulants oraux directs dans la maladie thromboembolique veineuse
Roffé, A., Guédon, A. F., & Lallmahomed, E. (2021) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2021.06.005 · Cited by 4
Pulmonary artery thrombosis: strategy of anticoagulation
Porembskaya, О. Y., Кравчук, В. Н., Lobastov, K. V., Kuzmina-Krutetskaya, S. R., Laberko, L. A., Chesnokov, M. S., Velikanova, K. E., & Saiganov, S. A. (2021) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia202111176 · Cited by 4
Duerschmied, D., Nitschmann, S., & Bode, C. (2013) · Der Internist · doi:10.1007/s00108-013-3377-6 · Cited by 4
Morris, T. A., & Fedullo, P. F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00057-9 · Cited by 4
Aspirin for preventing venous thromboembolism.
Brighton, T., Eikelboom, J. W., & Simes, J. (2013) · PubMed · doi:10.1056/nejmc1215492 · Cited by 3
Wavetable Synthesis Using CVAE for Timbre Control Based on Semantic Label
Yutani, T., Yamamoto, Y., Nakatani, S., & Terasawa, H. (2024) · Asia-Pacific Signal and Information Processing Association Annual Summit and Conference (APSIPA ASC) · doi:10.1109/apsipaasc63619.2025.10848699 · Cited by 3
Clinical Pharmacology of Aspirin
Pacifici, G. M. (2024) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2024.57.009037 · Cited by 3
Albukhari, A. F., AlHarbi, Y., Alqahtani, M. M., Hageen, A. W., Ibrahim, A. A., Alhomidani, F., Alshammari, T. G., Albalawi, T., Alshehri, S., Alayidh, M. A., et al. (2025) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2025.2554467 · Cited by 3
Risks and Benefits of Nonsteroidal Anti-inflammatory Drugs in the Hemostatic System
Cignarella, A., Campello, E., Ramaschi, G. E., Simion, C., & Simioni, P. (2025) · Seminars in Thrombosis and Hemostasis · doi:10.1055/a-2725-6989 · Cited by 3
Li, L., Brinkmann, T., Temmen, T., Eisenbarth, M., & Andert, J. (2025) · IEEE International Conference on Intelligent Transportation Systems (ITSC) · doi:10.1109/itsc60802.2025.11423781 · Cited by 3
Top practice-changing articles over the last two years
Kaatz, S., & Gage, B. F. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0896-x · Cited by 3
Density Estimation Helps Adversarial Robustness
Hasanebrahimi, A., Baghbaderani, B. K., Hosseini, R., & Kalhor, A. (2023) · International Conference on Computer and Knowledge Engineering · doi:10.1109/iccke60553.2023.10326257 · Cited by 3
Chen, Y., Jiao, W., Wang, Y., Liang, Z., Wang, L., Li, D., Liang, Y., & Niu, H. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.03.015 · Cited by 3
Arterial and venous thrombosis: shared risk factors and pathophysiology
Angchaisuksiri, P. (2019) · Journal of Hematology and Transfusion Medicine (วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต) · Cited by 3
Toth, P. P. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.912833 · Cited by 3
Vardi, M., Piazza, G., Pencina, M. J., Burke, D., Lei, L., Goldhaber, S. Z., & Cutlip, D. E. (2014) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029613517166 · Cited by 3
Pharmacological management of pulmonary embolism
Gouin, B., Robert‐Ebadi, H., Righini, M., & Blondon, M. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1268122 · Cited by 3
Strategien zur Antikoagulation bei Patienten mit tiefer Beinvenenthrombose und Lungenarterienembolie
Radke, P. W., & Möckel, M. (2017) · Herz · doi:10.1007/s00059-017-4655-1 · Cited by 3
ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLIC COMPLICATIONS: PROBLEMS AND PERSPECTIVES
Vorobieva, N. M., & Панченко, Е. П. (2015) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2015-2-7-17 · Cited by 3
Treatment of Acute Venous Thromboembolism
Nair, S. N., Garza, N., George, M., & Kaatz, S. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.03.004 · Cited by 3
Probablistic Restoration with Adaptive Noise Sampling for 3D Human Pose Estimation
Zeng, X., Qin, H., Kong, M. C., Chen, L., & Zhu, Q. (2024) · IEEE International Conference on Multimedia and Expo (ICME) · doi:10.1109/icme57554.2024.10687670 · Cited by 3
Jiménez, D., & Uresandi, F. (2014) · Angiología · doi:10.1016/j.angio.2014.02.003 · Cited by 3
Anticoagulation after venous thromboembolism: Deciding on the optimal duration
Eichinger, S. (2013) · Hämostaseologie · doi:10.5482/hamo-13-03-0015 · Cited by 3
Platelets as Regulators of Thrombosis and Inflammation
Duerschmied, D., & Maßberg, S. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-66224-4_4 · Cited by 3
Extended oral anticoagulation after incident venous thromboembolism – a paradigm shift?
Albertsen, I. E., Piazza, G., Søgaard, M., Nielsen, P. B., & Larsen, T. B. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1755260 · Cited by 3
Almudévar, A., Mariotte, T., Ortega, A., & Tahon, M. (2024) · IEEE International Conference on Acoustics Speech and Signal Processing · doi:10.1109/icassp48485.2024.10446649 · Cited by 3
Treatment and Long-Term Management of Venous Thromboembolism
AlBadri, A., & Spyropoulos, A. C. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.06.011 · Cited by 3
Anticoagulation Beyond 3 to 6 Months: What Does the Data Tell Us?
Carman, T. L. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.04.002 · Cited by 3
Metadata
- Authors
- Brighton, T. A., Eikelboom, J. W., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., Kirby, A., & Simes, J.
- Affiliations
- Prince of Wales Hospital (AU)
- Population Health Research Institute (CA)
- The University of Sydney (AU)
- South Australia Pathology (AU)
- Auckland City Hospital (NZ)
- The Alfred Hospital (AU)
- St.John's Medical College Hospital (IN)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-11-22
- Volume
- 367
- Issue
- 21
- Pages
- 1979-1987
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2162531249
- Cited by
- 563
- References
- 24
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 39 · 2023: 24 · 2022: 25 · 2021: 33 · 2020: 37 · 2019: 30 · 2018: 35 · 2017: 49 · 2016: 51 · 2015: 56 · 2014: 60 · 2013: 69 · 2012: 8
- FWCI
- 41.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- low-dose aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, anticoagulation discontinuation, secondary prevention, cardiovascular events, bleeding risk, major vascular events, net clinical benefit, thromboprophylaxis, stroke, myocardial infarction
- MeSH terms
- Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk, Incidence, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.